[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.211.120.181. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
November 1981

Etretinate in the Treatment of Juvenile Pityriasis Rubra Pilaris

Author Affiliations

From the Department of Dermatology, Universitäts-Hautklinik, Münster, West Germany.

Arch Dermatol. 1981;117(11):749-750. doi:10.1001/archderm.1981.01650110071026
Abstract

Oral retinoids have been reported to be effective in the treatment of pityriasis rubra pilaris (PRP).1,2 These compounds are far less toxic than vitamin A, although vitamin A is still recommended for the treatment of PRP by some authors.3 We report herein favorable results obtained with etretinate therapy in two children with PRP.

Report of Cases 

Case 1.—  An 8-year-old girl had had PRP since the age of 5 years. The disease had started with small patches of follicular hyperkeratosis on the arms. Despite treatment with 0.1% triamcinolone acetonide and 0.1% betamethasone valerate, the dermatitis had progressively involved more and more areas of the body. On physical examination, large patches of follicular hyperkeratosis and erythema with central hypopigmentation affected about 50% of the body surface, including the face and scalp. The palms and soles showed erythema and scaling, and multiple pits were present in the fingernails. The diagnosis

First Page Preview View Large
First page PDF preview
First page PDF preview
×